Clinical Trial

TRIM25 in Septic Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 6, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Sepsis is a life-threatening condition caused by the body's overwhelming response to infection, which can lead to organ damage and failure. The goal of this observational study is to better understand the underlying biological changes that occur in patients with sepsis compared to those who do not have the condition. We will collect peripheral blood samples from patients diagnosed with sepsis and from non-sepsis control participants. From these samples, we will isolate peripheral blood mononuclear cells (PBMCs) and serum. We will then analyze these components to measure the activity of specific genes and the levels of key inflammatory factors (cytokines). The information we gather will help researchers identify molecular and inflammatory markers associated with sepsis. This knowledge is crucial for developing new and more effective methods for diagnosing and treating this critical illness.
Trial Details
NCT Number NCT07320638
Lead Sponsor Ruijin Hospital
Conditions Sepsis
Enrollment 65 participants
Start Date 2021-12-10
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-06